Scitus Pharma Services Private Limited

Scitus Pharma Services Private Limited - pharma in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
CIN U74999TN2017PTC118805 Incorporated 26 September 2017 ROC Chennai HQ Chennai, Tamil Nadu, India
Active Private Limited Company pharma MSME · Medium
Data last updated
Revenue · FY 2025
₹43.45 Cr
▲ 17% YoY
Net profit · FY 2025
₹3.88 Cr
Net margin 8.9%
EBITDA · FY 2025
₹8.76 Cr
EBITDA margin 20.2%
Authorised capital
₹16 Cr
Registered with MCA
Paid-up capital
₹14.52 Cr
Issued & subscribed
Company age
9 yrs
Est. 2017
Employees · EPFO
157
Provident fund records
Directors on board
4
As per MCA filings

About Scitus Pharma Services Private Limited

Data last updated:

Scitus Pharma Services Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 26 September 2017 and has been in existence for over 9 years.

The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U74999TN2017PTC118805. Its GSTIN is 33AAZCS2737E1Z2 (Tamil Nadu).

The company has an authorised share capital of ₹16 Cr and a paid-up capital of ₹14.52 Cr. It is led by directors including Ayyavu Rajavel and Shanmugam Muthusamy.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Chennai, Tamil Nadu.

As per the financials filed for FY 2025, the company reported a revenue of ₹43.45 Cr, a growth of 17% compared to the previous year. For the same year it recorded a net profit of ₹3.88 Cr (net margin 8.9%) and EBITDA of ₹8.76 Cr (EBITDA margin 20.2%). Revenue has grown at a compounded annual rate (CAGR) of 20% over three years and 35% over five years.

The company has about 157 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Scitus. Court records list 9 cases involving the company, including 9 filed by the company; 1 case is pending. The company has 10 deals on record (5 funding rounds, 3 rights issues, 2 secondary share transfers), with disclosed funding of ₹10.7 Cr; the latest was in June 2022. Its 4 peer companies in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development) are compared by revenue, 1 larger and 3 smaller; the largest is Vivo Bio Tech Limited with revenue of ₹45.49 Cr. The company has 1 MSME Form 1 return on record for the period ending Jan 2019, listing 1 overdue payment to 1 micro and small supplier.

Scitus Pharma Services Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-24-0070727). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website scituspharma.com.

Company details

CIN U74999TN2017PTC118805
Registration Number 118805
Incorporation Date 26 September 2017
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-TN-24-0070727

Recognitions & Rankings of Scitus Pharma Services

MSME (Udyam registered) Ministry of MSME
Category
Medium (2024-25)
Udyam number
UDYAM-TN-24-0070727

Contact details

Scitus Pharma Services Private Limited's registered office is in Chennai, Tamil Nadu. Its website is scituspharma.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Module No.24 32 33 34 35 36&37 2nd Floor SIDCO Complex SIDCO Industrial Estate Thirumaz, Hisai, Chennai, Tamil Nadu, India – 600124
  • Industry
    Pharma, Pharma Contract R&D

To see the full contact details of Scitus Pharma Services Private Limited, buy the company report.

Comprehensive company report
Scitus Pharma Services Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Scitus Pharma Services operates one associated brand: Scitus. Each brand links to its own profile.

BrandDescriptionWebsite
Provides contract research services including clinical trials and bioanalytical studies.scituspharma.com

Business activity

The main business activity of Scitus Pharma Services is professional, scientific and technical. In detail, this covers scientific research and development.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
MProfessional, Scientific and TechnicalM5Scientific research and development

To see the full business activity and turnover split of Scitus Pharma Services Private Limited, buy the company report.

Financials of Scitus Pharma Services Private Limited

FY 2024 filings available

Scitus Pharma Services Private Limited reported revenue of ₹43.45 Cr (up 17% YoY) for FY 2025.

Revenue · FY 2025
₹43.45 Cr ▲ 17%
Net profit · FY 2025
₹3.88 Cr margin 8.9%
EBITDA · FY 2025
₹8.76 Cr margin 20.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 17%
3 years · compounded
▲ 20%
5 years · compounded
▲ 35%
EBITDA CAGR growth
1 year
▲ 8%
3 years · compounded
▲ 16%
5 years · compounded
▲ 51%

Revenue has grown at a compounded annual rate (CAGR) of 35% over five years, including 17% growth in the latest year. EBITDA rose 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹8.76 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹3.88 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin20.2%
Net Profit Margin8.9%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Scitus Pharma Services Private Limited, buy the company report.

Board of directors of Scitus Pharma Services Private Limited

Scitus Pharma Services has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Ayyavu RajavelDirector26 Sep 20179 Years 1 MonthsCurrent
Shanmugam MuthusamyDirector26 Sep 20179 Years 1 MonthsCurrent
SankarDirector01 Oct 20215 Years 1 MonthsCurrent
Sruthi Nandhaa ShanmugamDirector01 Oct 20215 Years 1 MonthsCurrent

Peer comparison

Scitus Pharma Services Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Vivo Bio Tech Limited₹45.49 Cr (FY 2024)-13.0%Hyderabad, Telangana, India
Scitus Pharma Services Private Limitedthis company₹43.45 Cr (FY 2025)₹3.88 Cr8.9%17.0%157Chennai, Tamil Nadu, India
Energon Labs Private Limited₹42.42 Cr (FY 2024)48.0%Hyderabad, Telangana, India
Enem Nostrum Remedies Private Limited₹42.33 Cr (FY 2025)-13.0%Mumbai, Maharashtra, India
Onecell Diagnostics India Private Limited₹41.91 Cr (FY 2025)95.0%Pune, Maharashtra, India

To see the full peer comparison of Scitus Pharma Services Private Limited, buy the company report.

Auditor

Scitus Pharma Services Private Limited is audited by SENTHIL RAJA AND ASSOCIATES for the financial year 2023.

Auditor firmFinancial yearFirm registration number
SENTHIL RAJA AND ASSOCIATESFY 2023012995S

Shareholding

The shareholding of Scitus Pharma Services Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Scitus Pharma Services Private Limited, buy the company report.

Deals & funding

Scitus Pharma Services Private Limited has 10 deals on record (5 funding rounds, 3 rights issues, 2 secondary share transfers), with disclosed funding of ₹10.7 Cr; the latest was in June 2022.

Total deals
10
Funding rounds
5
Rights issues
3
Secondary share transfers
2
Disclosed funding
₹10.7 Cr

Deals on record (5 of 10)

WhenDealAmountParties
Jun 2022Funding round₹30 LakhInvestors: an individual
Jun 2020Funding round₹3.4 CrInvestors: 3 individuals
May 2020Secondary share transferUndisclosedBuyer: an individual
Seller: 2 individuals
Jul 2019Funding round₹3.2 CrInvestors: 3 individuals
Jan 2019Funding round₹2.8 CrInvestors: 2 individuals

To see the full deal history of Scitus Pharma Services Private Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Scitus Pharma Services Private Limited has 1 MSME Form 1 return on record for the period ending Jan 2019, listing 1 overdue payment to 1 micro and small supplier. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (1 of 1)

SupplierAmount dueDue sinceReported on
Vivan Life Sciences Private Limited

To see the full MSME payment records of Scitus Pharma Services Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Scitus Pharma Services Private Limited has a workforce of 157 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.

Employee count
157
Active EPFO establishments
1
Employee growth
1.95%

GST

Scitus Pharma Services has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
33AAZCS2737E1Z2Tamil NaduActive25 Oct 2017

To see the full GST registrations and return filing status of Scitus Pharma Services Private Limited, buy the company report.

Recent activity

Scitus Pharma Services Private Limited has 7 board changes on record since 2017: 4 appointments and 3 cessations. The latest: Sankar ceased to be Additional Director on 30 Nov 2021.

AGM
Scitus Pharma Services Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Scitus Pharma Services Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai.
Ceased
Sankar ceased to be Additional Director.
Ceased
Sruthi Nandhaa Shanmugam ceased to be Additional Director.
Appointed
Sankar was appointed as Director.
Appointed
Sruthi Nandhaa Shanmugam was appointed as Director.
Ceased
Jayanthy Ayyavu Shanmugam ceased to be Additional Director.
Appointed
Ayyavu Rajavel was appointed as Director.
Appointed
Shanmugam Muthusamy was appointed as Director.
Incorporation
26 Sep 2017
Scitus Pharma Services Private Limited was registered on 26 Sep 2017 with Roc Chennai & aged 9 years 1 month as per MCA records.

Frequently asked questions

Scitus Pharma Services is an active private limited company based in Chennai, Tamil Nadu, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 26 September 2017 (9+ years old) and is registered under CIN U74999TN2017PTC118805.

Scitus Pharma Services has 4 current directors:

The latest financial statements of Scitus Pharma Services on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2018 are in the company report.

The GSTIN of Scitus Pharma Services is 33AAZCS2737E1Z2, registered in Tamil Nadu.

The CIN (Corporate Identification Number) of Scitus Pharma Services is U74999TN2017PTC118805. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Scitus Pharma Services has 9 court cases on record: 9 filed by the company. 1 is pending.

Scitus Pharma Services was incorporated on 26 September 2017, making it 9+ years old. It is registered with the Registrar of Companies, Chennai.

Scitus Pharma Services has 10 deals on record (5 funding rounds, 3 rights issues, 2 secondary share transfers), with disclosed funding of ₹10.7 Cr; the latest was in June 2022.

The peers of Scitus Pharma Services by revenue are Vivo Bio Tech Limited, Energon Labs Private Limited, Enem Nostrum Remedies Private Limited, Onecell Diagnostics India Private Limited, all in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development).

Sankar ceased to be Additional Director on 30 Nov 2021. Sruthi Nandhaa Shanmugam ceased to be Additional Director on 30 Nov 2021. Sankar was appointed as Director on 01 Oct 2021. Scitus Pharma Services has 7 board changes on record in total.

Yes, Scitus Pharma Services is registered as a medium enterprise under Udyam registration (number: UDYAM-TN-24-0070727).

Scitus Pharma Services has 1 MSME Form 1 return on record for the period ending Jan 2019, listing 1 overdue payment to 1 micro and small supplier. The latest return was filed on 04 Jun 2019.